球囊扩张支架与自膨式支架治疗侧支循环欠佳的症状性颅内动脉狭窄的临床研究
Balloon-Mounted Stent versus Self-Expanding Stent for Symptomatic Intracranial Artery Stenosis Combined with Poor Collateral Circulation
摘要: 目的:比较球囊扩张支架与自膨式支架治疗侧支循环欠佳的症状性颅内动脉狭窄患者1年的临床疗效。方法:收集中国20家医院2013年9月至2015年1月接受球囊扩张支架或自膨式支架的258名症状性颅内动脉狭窄合并侧支循环不良患者为研究对象,对患者基线特征及临床疗效进行评估。结果:总体平均狭窄程度由支架植入前的83.73 ± 10.40%降至支架植入后的8.5 ± 7.96%。自膨式支架治疗的患者接受全身麻醉的比例高于球囊扩张支架治疗的患者(81.5% VS 62.7%, P = 0.001),且手术时间更长(93.53 ± 24.11 min VS 68.09 ± 16.74 min, P < 0.001)。使用自膨式支架治疗的患者需要更长和更大直径的支架(分别为14.44 ± 3.09 mm VS 9.67 ± 2.57 mm,P < 0.001,3.06 ± 0.47 mm VS 2.69 ± 0.27 mm,P < 0.001)。自膨式支架患者的残余狭窄率高于球囊扩张支架患者(11.36 ± 8.26% VS 5.99 ± 6.48%,P < 0.001),两组中使用自膨式支架的患者再狭窄发生率高(11/124 VS 21/112,P=0.027),且再狭窄程度也较球囊扩张支架高(36.2 ± 18.33 VS 48.5 ± 24.51%, P < 0.001)。1年随访期间,两组出现缺血性卒中、出血性卒中、短暂性脑缺血发作、死亡的发生率无显著差异(分别是P = 0.722、0.105、0.725、1.000)。结论:对于严重颅内动脉狭窄且合并侧支循环不良的患者,进行支架植入术相对安全。球囊扩张支架较自膨式支架的手术时间更短,发生再狭窄的机率及再狭窄程度更低,但两者1年随访结局无明显差异。
Abstract: Objective: To compare the 1-year clinical outcome of balloon-mounted stent versus self-expanding stent in the treatment of symptomatic intracranial artery stenosis combined with poor collateral circulation. Method: A total of 258 patients with symptomatic intracranial artery stenosis combined with poor collateral circulation were enrolled in the study. Balloon-mounted stent and self-expanding stent were selected according to the vascular conditions of the patients, then the baseline characteristics and clinical outcome of the patients were compared. Results: The overall mean degree of stenosis decreased from 83.73 ± 10.40% to 8.5 ± 7.96%. Patients treated with self-expanding stent were more likely to receive general anesthesia (81.5% vs 62.7%, P = 0.001), and the operation time was longer than balloon-mounted stent (93.53 ± 24.11 min vs 68.09 ± 16.74 min, P < 0.001). Patients treated with self-expanding stent need longer and larger diameter stents than balloon-mounted stent (14.44 ± 3.09 mm vs 9.67 ± 2.57 mm, P < 0.001, 3.06 ± 0.47 mm vs 2.69 ± 0.27 mm, respectively, P < 0.001), the residual stenosis rate of patients with self-expanding stent was higher than patients treated with balloon-mounted stent (11.36 ± 8.26% vs 5.99 ± 6.48%, P < 0.001), and the restenosis rate of patients with self-expanding stent was higher than that patients treated with balloon-mounted stent (11/124 vs 21/112, P = 0.027), the restenosis degree was also higher than the patients treated with balloon-mounted stent (36.2 ± 18.33 vs 48.5 ± 24.51%, P < 0.001). The rates of stroke, transient ischemic attack or death at 1-year follow-up were not significantly different between two groups (P = 0.722, 0.105, 0.725 and 1.000, respectively). Conclusions: For patients with severe intracranial artery stenosis combined with poor collateral circulation, stent implantation can be performed safely. Compared with self-expanding stent, the operation time of balloon expanding stent is shorter, and the probability and degree of restenosis are lower, but there is not any significant difference in 1-year follow-up results between the 2 groups.
文章引用:丁鸿斐, 滕文慧, 付蕾, 张贤军, 荣婷, 姜英, 张勇, 王乃东. 球囊扩张支架与自膨式支架治疗侧支循环欠佳的症状性颅内动脉狭窄的临床研究[J]. 临床医学进展, 2021, 11(4): 1473-1481. https://doi.org/10.12677/ACM.2021.114211

参考文献

[1] Zhou, M., Wang, H., Zeng, X., et al. (2019) Mortality, Morbidity, and Risk Factors in China and Its Provinces, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. Lancet, 394, 1145-1158. [Google Scholar] [CrossRef
[2] Holmstedt, C.A., Turan, T.N. and Chimowitz, M.I. (2013) Atherosclerotic Intracranial Arterial Stenosis: Risk Factors, Diagnosis, and Treatment. The Lancet Neurology, 12, 1106-1114. [Google Scholar] [CrossRef
[3] Kasner, S.E., Lynn, M.J., Chimowitz, M.I., et al. (2006) Warfarin vs Aspirin for Symptomatic Intracranial Stenosis: Subgroup Analyses from WASID. Neurology, 67, 1275-1278. [Google Scholar] [CrossRef] [PubMed]
[4] Li, T.X., Gao, B.L., Cai, D.Y., et al. (2015) Wingspan Stenting for Severe Symptomatic Intracranial Atherosclerotic Stenosis in 433 Patients Treated at a Single Medical Center. PLoS One, 10, e0139377. [Google Scholar] [CrossRef] [PubMed]
[5] Tang, C.-W., Chang, F.-C., Chern, C.-M., Lee, Y.-C., Hu, H.-H. and Lee, I.-H. (2011) Stenting versus Medical Treatment for Severe Symptomatic Intracranial Stenosis. American Journal of Neuroradiology, 32, 911-916. [Google Scholar] [CrossRef
[6] Alexander, M.J., Zauner, A., Chaloupka, J.C., et al. (2019) WEAVE Trial: Final Results in 152 On-Label Patients. Stroke, 50, 889-894. [Google Scholar] [CrossRef
[7] Yu, S.C., Leung, T.W.H., Hung, E.H.Y., Lee, K.T. and Wong, L.K.S. (2012) Angioplasty and Stenting for Intracranial Atherosclerotic Stenosis with Nitinol Stent: Factors Affecting Technical Success and Patient Safety. Operative Neurosurgery, 70, 104-113. [Google Scholar] [CrossRef
[8] Maier, I.L., Karch, A., Lipke, C., et al. (2018) Transluminal Angioplasty and Stenting versus Conservative Treatment in Patients with Symptomatic Basilar Artery Stenosis: Perspective for Future Clinical Trials. Clinical Neuroradiology, 28, 33-38. [Google Scholar] [CrossRef] [PubMed]
[9] Gao, P., Wang, D., Zhao, Z., et al. (2016) Multicenter Prospective Trial of Stent Placement in Patients with Symptomatic High-Grade Intracranial Stenosis. American Journal of Neuroradiology, 37, 1275-1280. [Google Scholar] [CrossRef
[10] 李宝民, 缪中荣, 王拥军, 徐安定, 曾进胜. 症状性颅内动脉粥样硬化性狭窄血管内治疗中国专家共识2018 [J]. 中国卒中杂志, 2018, 13(6): 594-604.
[11] Yue, X., Yin, Q., Xi, G., et al. (2011) Comparison of BMSs with SES for Symptomatic Intracranial Disease of the Middle Cerebral Artery Stenosis. CardioVascular and Interventional Radiology, 34, 54-60. [Google Scholar] [CrossRef] [PubMed]
[12] Zhang, Y., Rajah, G.B., Liu, P., et al. (2019) Balloon-Mounted versus Self-Expanding Stents for Symptomatic Intracranial Vertebrobasilar Artery Stenosis Combined with Poor Collaterals. Neurological Research, 41, 704-713. [Google Scholar] [CrossRef] [PubMed]
[13] Li, G., Wang, N., Li, X., et al. (2019) Balloon-Mounted versus Self-Expanding Stent Outcomes in Symptomatic Middle Cerebral Artery Stenosis Combined with Poor Collaterals in China: A Multicenter Registry Study. World Neurosurgery, 124, e675-e681. [Google Scholar] [CrossRef] [PubMed]
[14] Miao, Z., Zhang, Y., Shuai, J., et al. (2015) Thirty-Day Outcome of a Multicenter Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China. Stroke, 46, 2822-2829. [Google Scholar] [CrossRef
[15] Abe, A., Ueda, T., Ueda, M., et al. (2012) Symptomatic Middle Cerebral Artery Stenosis Treated by Percutaneous Transluminal Angioplasty: Improvement of Cerebrovascular Reserves. Interventional Neuroradiology, 18, 213-220. [Google Scholar] [CrossRef] [PubMed]
[16] Miao, Z., Song, L., Liebeskind, D.S., et al. (2015) Outcomes of Tailored Angioplasty and/or Stenting for Symptomatic Intracranial Atherosclerosis: A Prospective Cohort Study after SAMMPRIS. Journal of NeuroInterventional Surgery, 7, 331-335. [Google Scholar] [CrossRef] [PubMed]
[17] Zhang, Y., Sun, Y., Li, X., et al. (2020) Early versus Delayed Stenting for Intracranial Atherosclerotic Artery Stenosis with Ischemic Stroke. Journal of NeuroInterventional Surgery, 12, 274-278. [Google Scholar] [CrossRef] [PubMed]
[18] Miao, Z. (2014) Intracranial Angioplasty and Stenting before and after SAMMPRIS: “From Simple to Complex Strategy—The Chinese Experience”. Frontiers in Neurology, 5, 129. [Google Scholar] [CrossRef] [PubMed]
[19] Cassese, S., Byrne, R.A., Tada, T., et al. (2014) Incidence and Predictors of Restenosis after Coronary Stenting in 10004 Patients with Surveillance Angiography. Heart, 100, 153-159. [Google Scholar] [CrossRef] [PubMed]
[20] Jin, M., Fu, X., Wei, Y.Z., Du, B., Xu, X.T. and Jiang, W.J. (2013) Higher Risk of Recurrent Ischemic Events in Patients with Intracranial In-Stent Restenosis. Stroke, 44, 2990-2994. [Google Scholar] [CrossRef
[21] Mitra, A.K. and Agrawal, D.K. (2006) In Stent Restenosis: Bane of the Stent Era. Journal of Clinical Pathology, 59, 232-239. [Google Scholar] [CrossRef] [PubMed]
[22] Groschel, K., Schnaudigel, S., Pilgram, S.M., Wasser, K. and Kastrup, A. (2009) A Systematic Review on Outcome after Stenting for Intracranial Atherosclerosis. Stroke, 40, e340-e347. [Google Scholar] [CrossRef
[23] Sick, P., Hüttl, T., Niebauer, J., et al. (2003) Influence of Residual Stenosis after Percutaneous Coronary Intervention with Stent Implantation on Development of Restenosis and Stent Thrombosis. The American Journal of Cardiology, 91, 148-153. [Google Scholar] [CrossRef
[24] Suh, D.C., Kim, J.K., Choi, J.W., et al. (2008) Intracranial Stenting of Severe Symptomatic Intracranial Stenosis: Results of 100 Consecutive Patients. American Journal of Neuroradiology, 29, 781-785. [Google Scholar] [CrossRef
[25] Hartmann, M. and Jansen, O. (2005) Angioplasty and Stenting of Intracranial Stenosis. Current Opinion in Neurology, 18, 39-45. [Google Scholar] [CrossRef] [PubMed]
[26] Connors 3rd, J.J. and Wojak, J.C. (1999) Percutaneous Transluminal Angioplasty for Intracranial Atherosclerotic Lesions: Evolution of Technique and Short-Term Results. Journal of Neurosurgery, 91, 415-423. [Google Scholar] [CrossRef] [PubMed]
[27] Bose, A., Hartmann, M., Henkes, H., et al. (2007) A Novel, Self-Expanding, Nitinol Stent in Medically Refractory Intracranial Atherosclerotic Stenoses: The Wingspan Study. Stroke, 38, 1531-1537. [Google Scholar] [CrossRef
[28] 王云, 王连芹, 李英毅, 等. 球囊扩张支架多梯次压力释放在症状性颅内动脉粥样硬化性狭窄中的疗效分析[J]. 中国脑血管病杂志, 2020, 17(3): 117-125.
[29] 童晨光, 李慎茂, 缪中荣, 焦力群, 朱凤水. 球囊扩张支架与自膨式支架治疗症状性颅内动脉重度狭窄的比较[J]. 中国脑血管病杂志, 2011, 8(1): 13-17.